These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9371360)

  • 41. Pharmacodynamic properties of faropenem demonstrated by studies of time-kill kinetics and postantibiotic effect.
    Boswell FJ; Andrews JM; Wise R
    J Antimicrob Chemother; 1997 Mar; 39(3):415-8. PubMed ID: 9096193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
    Hanberger H
    Scand J Infect Dis Suppl; 1992; 81():1-52. PubMed ID: 1322561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004.
    Melo-Cristino J; Santos L; Ramirez M;
    Rev Port Pneumol; 2006; 12(1):9-30. PubMed ID: 16572254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
    Visalli MA; Jacobs MR; Appelbaum PC
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
    Noviello S; Ianniello F; Leone S; Esposito S
    J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.
    Fuentes F; Izquierdo J; Martín MM; Gomez-Lus ML; Prieto J
    Antimicrob Agents Chemother; 1998 Feb; 42(2):414-8. PubMed ID: 9527796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.
    Nielsen EI; Viberg A; Löwdin E; Cars O; Karlsson MO; Sandström M
    Antimicrob Agents Chemother; 2007 Jan; 51(1):128-36. PubMed ID: 17060524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization.
    Nielsen EI; Cars O; Friberg LE
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4619-30. PubMed ID: 21807983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activity of oral antibiotics against respiratory tract pathogens in Spain.
    Calvo A; Amores R; Valero E; Fuentes F; Gómez-Lus ML; Prieto J;
    Rev Esp Quimioter; 2003 Dec; 16(4):436-43. PubMed ID: 14961138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance.
    Burgess DS; Hastings RW; Horan JL
    Ann Pharmacother; 1999 Dec; 33(12):1262-5. PubMed ID: 10630825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An in vivo model for evaluation of the postantibiotic effect.
    Odenholt I; Holm SE; Cars O
    Scand J Infect Dis; 1988; 20(1):97-103. PubMed ID: 3283924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postantibiotic effects and postantibiotic sub-MIC effects of benzylpenicillin on viridans streptococci isolated from patients with infective endocarditis.
    Kikuchi K; Enari T; Minami S; Haruki K; Shibata Y; Hasegawa H; Katahira J; Totsuka K; Shimizu K
    J Antimicrob Chemother; 1994 Nov; 34(5):687-96. PubMed ID: 7706164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae.
    Bergman KL; Olsen KM; Peddicord TE; Fey PD; Rupp ME
    Antimicrob Agents Chemother; 1999 May; 43(5):1291-3. PubMed ID: 10223956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
    Louie A; Baltch AL; Ritz WJ; Smith RP
    Chemotherapy; 1991; 37(4):275-82. PubMed ID: 1665123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative antimicrobial activity and post-antibiotic effect of azithromycin, clarithromycin and roxithromycin against some respiratory pathogens.
    Ferrara A; Dos Santos C; Cimbro M; Grassi GG
    Int J Antimicrob Agents; 1996 Aug; 7(3):181-6. PubMed ID: 18611754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
    Horgen L; Legrand E; Rastogi N
    Res Microbiol; 1997 Nov; 148(8):673-81. PubMed ID: 9765852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
    Hoellman DB; Lin G; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistent acylation of high-molecular-weight penicillin-binding proteins by penicillin induces the postantibiotic effect in Streptococcus pyogenes.
    Yan S; Bohach GA; Stevens DL
    J Infect Dis; 1994 Sep; 170(3):609-14. PubMed ID: 8077718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
    Forsgren A; Walder M
    Acta Otolaryngol Suppl; 1984; 407():43-9. PubMed ID: 6437134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.